OLMA (Olema Pharmaceuticals) Other Current Liabilities: $2.20 Mil (As of Mar. 2026)


OLMA Olema Pharmaceuticals inc OLMA
33 GF Score
Price $12.64
! 2 Warning Signs
View Full Analysis

What is Olema Pharmaceuticals Other Current Liabilities?

Olema Pharmaceuticals OLMA +4.72% 33 Other Current Liabilities is $2.20 Mil as of Mar. 2026. GuruFocus rates OLMA with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

Olema Pharmaceuticals's other current liabilities for the quarter that ended in Mar. 2026 was $2.20 Mil.

Olema Pharmaceuticals's quarterly other current liabilities increased from Sep. 2025 ($5.29 Mil) to Dec. 2025 ($8.25 Mil) but then declined from Dec. 2025 ($8.25 Mil) to Mar. 2026 ($2.20 Mil).

Olema Pharmaceuticals's annual other current liabilities increased from Dec. 2023 ($5.47 Mil) to Dec. 2024 ($5.66 Mil) and increased from Dec. 2024 ($5.66 Mil) to Dec. 2025 ($8.25 Mil).

Olema Pharmaceuticals Other Current Liabilities Related Terms

Olema Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Olema Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olema Pharmaceuticals Other Current Liabilities Chart

Olema Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 3.96 4.60 5.47 5.66 8.25

Olema Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.63 3.39 5.29 8.25 2.20
OLMA
33GF Score
Olema Pharmaceuticals inc OLMA
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olema Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $2.20 Mil mean?
Olema Pharmaceuticals (OLMA) has a Other Current Liabilities of $2.20 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Olema Pharmaceuticals.
Is Olema Pharmaceuticals' Other Current Liabilities too high?
Olema Pharmaceuticals' current Other Current Liabilities is $2.20 Mil. Overall, Olema Pharmaceuticals has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Olema Pharmaceuticals' Other Current Liabilities compare to DRTS and ORIC?
Olema Pharmaceuticals' Other Current Liabilities of $2.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Olema Pharmaceuticals. Olema Pharmaceuticals's current Other Current Liabilities is $2.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olema Pharmaceuticals stock overvalued right now?
Olema Pharmaceuticals (OLMA) has a current Other Current Liabilities of $2.20 Mil. The current Other Current Liabilities is $2.20 Mil. Olema Pharmaceuticals' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Olema Pharmaceuticals (OLMA), the current Other Current Liabilities is $2.20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Olema Pharmaceuticals Business Description

Address 780 Brannan Street, San Francisco, CA, USA, 94103
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
33GF Score

Get the complete analysis for OLMA

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.64
Price